The progress in human disease treatment can be greatly advanced through the
implementation of nanomedicine. This approach involves targeted and cell-specific therapy …

Chronic respiratory diseases like asthma and Chronic Obstructive Pulmonary Disease
(COPD) have been a burden to society for an extended period. Currently, there are only …

Add-on biological therapy has proven to be effective in many patients with severe
eosinophilic asthma. In this observational multicenter retrospective study, we report the …

Several current guidelines/strategies outline a treatment approach to asthma, which
primarily consider the goals of improving lung function and quality of life and reducing …

In recent years, RNA-based therapies have gained much attention as biomedicines due to
their remarkable therapeutic effects with high specificity and potency. Lung diseases offer a …

Respiratory syncytial virus (RSV) and Rhinovirus (RV) infections are major triggers of severe
lower respiratory illnesses (sLRI) in infants and children and are strongly associated with the …

(1) Background: Over the past 20 years, monoclonal antibodies have been developed for
the treatment of severe asthma, with numerous randomised controlled trials (RCTs) …

Asthma is a chronic complex pulmonary disease characterized by airway inflammation,
remodeling, and hyperresponsiveness. Vascular endothelial growth factor (VEGF) and …

NKT cells, unique lymphocytes bridging innate and adaptive immunity, offer significant
potential for managing inflammatory disorders like asthma. Activating iNKT induces …

Chronic respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD) and
asthma have posed a significant healthcare and economic cost over a prolonged duration …